Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03097809 · ClinicalTrials.gov registry record

SEEG Investigation of Mood Dysregulation in Epilepsy

A clinical trial, sponsored by The Cleveland Clinic.

Completed
Registry status
8
Enrollment target

NCT03097809 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03097809 has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
8 participants
Enrollment target

Study Summary

Using the novel analysis of stereo-electroencephalography (SEEG) recordings, this proposal will investigate the activity and connectivity of mood regulation circuits in subjects with suspected epileptic focus who have undergone SEEG electrode implantation for monitoring of seizure activity.

Interventions

  • OTHER SEEG Recordings

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2017-02-27
Est. Completion 2020-07-01

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT03097809

The ClinicalTrials.gov registry entry for NCT03097809 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which SEEG Recordings is the first listed.

NCT03097809 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03097809 about?

NCT03097809 is a clinical study titled "SEEG Investigation of Mood Dysregulation in Epilepsy". Using the novel analysis of stereo-electroencephalography (SEEG) recordings, this proposal will investigate the activity and connectivity of mood regulation circuits in subjects with suspected epileptic focus who have undergone SEEG electrode implantation for monitoring of seizure activity.

What is the current status of trial NCT03097809?

This trial is currently completed. The enrollment target is 8 participants. The study started on 2017-02-27. Estimated completion is 2020-07-01.

What interventions are being tested in trial NCT03097809?

The interventions under investigation include: SEEG Recordings (OTHER).

Who is sponsoring clinical trial NCT03097809?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.